Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Third Tofo Advanced Study Week on Emerging and Re-emerging Viruses, 2018.

Badolo A, Burt F, Daniel S, Fearns R, Gudo ES, Kielian M, Lescar J, Shi Y, von Brunn A, Weiss SR, Hilgenfeld R.

Antiviral Res. 2019 Feb;162:142-150. doi: 10.1016/j.antiviral.2018.12.015. Epub 2018 Dec 28. Review.

PMID:
30597184
2.

p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLpro via E3 ubiquitin ligase RCHY1.

Ma-Lauer Y, Carbajo-Lozoya J, Hein MY, Müller MA, Deng W, Lei J, Meyer B, Kusov Y, von Brunn B, Bairad DR, Hünten S, Drosten C, Hermeking H, Leonhardt H, Mann M, Hilgenfeld R, von Brunn A.

Proc Natl Acad Sci U S A. 2016 Aug 30;113(35):E5192-201. doi: 10.1073/pnas.1603435113. Epub 2016 Aug 12.

3.

Tubulins interact with porcine and human S proteins of the genus Alphacoronavirus and support successful assembly and release of infectious viral particles.

Rüdiger AT, Mayrhofer P, Ma-Lauer Y, Pohlentz G, Müthing J, von Brunn A, Schwegmann-Weßels C.

Virology. 2016 Oct;497:185-197. doi: 10.1016/j.virol.2016.07.022. Epub 2016 Jul 30.

4.

Editorial overview: Engineering for viral resistance.

von Brunn A.

Curr Opin Virol. 2015 Oct;14:v-vii. doi: 10.1016/j.coviro.2015.08.009. Epub 2015 Aug 28. No abstract available.

PMID:
26320757
5.

Genetic deficiency and polymorphisms of cyclophilin A reveal its essential role for Human Coronavirus 229E replication.

von Brunn A, Ciesek S, von Brunn B, Carbajo-Lozoya J.

Curr Opin Virol. 2015 Oct;14:56-61. doi: 10.1016/j.coviro.2015.08.004. Epub 2015 Aug 27. Review.

PMID:
26318518
6.

Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir.

Carbajo-Lozoya J, Ma-Lauer Y, Malešević M, Theuerkorn M, Kahlert V, Prell E, von Brunn B, Muth D, Baumert TF, Drosten C, Fischer G, von Brunn A.

Virus Res. 2014 May 12;184:44-53. doi: 10.1016/j.virusres.2014.02.010. Epub 2014 Feb 22.

PMID:
24566223
7.

Comprehensive analysis of varicella-zoster virus proteins using a new monoclonal antibody collection.

Lenac Roviš T, Bailer SM, Pothineni VR, Ouwendijk WJ, Šimić H, Babić M, Miklić K, Malić S, Verweij MC, Baiker A, Gonzalez O, von Brunn A, Zimmer R, Früh K, Verjans GM, Jonjić S, Haas J.

J Virol. 2013 Jun;87(12):6943-54. doi: 10.1128/JVI.00407-13. Epub 2013 Apr 17.

8.

Virus-host interactomes--antiviral drug discovery.

Ma-Lauer Y, Lei J, Hilgenfeld R, von Brunn A.

Curr Opin Virol. 2012 Oct;2(5):614-21. doi: 10.1016/j.coviro.2012.09.003. Review.

PMID:
23057872
9.

Bacteriophage protein-protein interactions.

Häuser R, Blasche S, Dokland T, Haggård-Ljungquist E, von Brunn A, Salas M, Casjens S, Molineux I, Uetz P.

Adv Virus Res. 2012;83:219-98. doi: 10.1016/B978-0-12-394438-2.00006-2. Review.

10.

Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506.

Carbajo-Lozoya J, Müller MA, Kallies S, Thiel V, Drosten C, von Brunn A.

Virus Res. 2012 Apr;165(1):112-7. doi: 10.1016/j.virusres.2012.02.002. Epub 2012 Feb 10.

PMID:
22349148
11.

The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors.

Pfefferle S, Schöpf J, Kögl M, Friedel CC, Müller MA, Carbajo-Lozoya J, Stellberger T, von Dall'Armi E, Herzog P, Kallies S, Niemeyer D, Ditt V, Kuri T, Züst R, Pumpor K, Hilgenfeld R, Schwarz F, Zimmer R, Steffen I, Weber F, Thiel V, Herrler G, Thiel HJ, Schwegmann-Wessels C, Pöhlmann S, Haas J, Drosten C, von Brunn A.

PLoS Pathog. 2011 Oct;7(10):e1002331. doi: 10.1371/journal.ppat.1002331. Epub 2011 Oct 27.

12.

Crystal structure of the middle domain of human poly(A)-binding protein-interacting protein 1.

Lei J, Mesters JR, von Brunn A, Hilgenfeld R.

Biochem Biophys Res Commun. 2011 May 20;408(4):680-5. doi: 10.1016/j.bbrc.2011.04.088. Epub 2011 Apr 23.

PMID:
21539810
13.

Evolutionarily conserved herpesviral protein interaction networks.

Fossum E, Friedel CC, Rajagopala SV, Titz B, Baiker A, Schmidt T, Kraus T, Stellberger T, Rutenberg C, Suthram S, Bandyopadhyay S, Rose D, von Brunn A, Uhlmann M, Zeretzke C, Dong YA, Boulet H, Koegl M, Bailer SM, Koszinowski U, Ideker T, Uetz P, Zimmer R, Haas J.

PLoS Pathog. 2009 Sep;5(9):e1000570. doi: 10.1371/journal.ppat.1000570. Epub 2009 Sep 4.

14.

Analysis of intraviral protein-protein interactions of the SARS coronavirus ORFeome.

von Brunn A, Teepe C, Simpson JC, Pepperkok R, Friedel CC, Zimmer R, Roberts R, Baric R, Haas J.

PLoS One. 2007 May 23;2(5):e459.

15.

Mutations in the high-affinity IgE receptor beta-chain are not associated with nonresponder status.

Küster H, von Manstein S, Ruocchio-Wiglinghaus S, von Brunn A, Reinhardt D.

Allergy. 2005 Aug;60(8):1040-5.

PMID:
15969685
16.

Polyhistidine-tagged hepatitis B core particles as carriers of HIV-1/gp120 epitopes of different HIV-1 subtypes.

Wizemann H, Weiland F, Pfaff E, von Brunn A.

Biol Chem. 2000 Mar;381(3):231-43.

PMID:
10782994
17.

Analysis of 27 mammalian and 9 avian PrPs reveals high conservation of flexible regions of the prion protein.

Wopfner F, Weidenhöfer G, Schneider R, von Brunn A, Gilch S, Schwarz TF, Werner T, Schätzl HM.

J Mol Biol. 1999 Jun 25;289(5):1163-78.

PMID:
10373359
18.
19.

Epidemiological study of viral hepatitis types A, B, C, D and E among Inuits in West Greenland.

Langer BC, Frösner GG, von Brunn A.

J Viral Hepat. 1997 Sep;4(5):339-49.

PMID:
9310933
20.

Is codon 129 of prion protein polymorphic in human beings but not in animals?

Schätzl HM, Wopfner F, Gilch S, von Brunn A, Jäger G.

Lancet. 1997 May 31;349(9065):1603-4. No abstract available.

PMID:
9174569
21.

Genetically engineered HIV type 1 peptides as tools for the determination of anti-V3 loop antibody titers in sera from HIV type 1-infected patients.

Von Brunn A, Reichhuber C, Pfaff E, Wizemann H.

AIDS Res Hum Retroviruses. 1995 Dec;11(12):1459-65.

PMID:
8679289
22.

Analysis of the V3 loop sequences from 10 HIV type 1-infected AIDS patients from Paraguay.

Cabello A, Cabral M, Vera ME, Kiefer R, Azorero RM, Eberle J, Gürtler L, Von Brunn A.

AIDS Res Hum Retroviruses. 1995 Sep;11(9):1135-7.

PMID:
8554912
23.

New crown motif of an HIV-1 V3 loop sequence from a Ugandan AIDS patient.

von Brunn A, von Brunn B, Eberle J, Biryahwaho B, Downing RG, Gürtler L.

AIDS Res Hum Retroviruses. 1995 Jan;11(1):183-4.

PMID:
7734191
24.

A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon.

Gürtler LG, Hauser PH, Eberle J, von Brunn A, Knapp S, Zekeng L, Tsague JM, Kaptue L.

J Virol. 1994 Mar;68(3):1581-5.

25.
26.

Principal neutralizing domain of HIV-1 is highly immunogenic when expressed on the surface of hepatitis B core particles.

von Brunn A, Brand M, Reichhuber C, Morys-Wortmann C, Deinhardt F, Schödel F.

Vaccine. 1993;11(8):817-24.

PMID:
7689283
27.

Heat stability of parvovirus B19: kinetics of inactivation.

Schwarz TF, Serke S, Von Brunn A, Hottenträger B, Huhn D, Deinhardt F, Roggendorf M.

Zentralbl Bakteriol. 1992 Jul;277(2):219-23.

PMID:
1520981
28.

Replication of parvovirus B19 in hematopoietic progenitor cells generated in vitro from normal human peripheral blood.

Schwarz TF, Serke S, Hottenträger B, von Brunn A, Baurmann H, Kirsch A, Stolz W, Huhn D, Deinhardt F, Roggendorf M.

J Virol. 1992 Feb;66(2):1273-6.

29.

Immunological reactivity of a human immunodeficiency virus type I derived peptide representing a consensus sequence of the GP120 major neutralizing region V3.

Wagner R, Modrow S, Böltz T, Fliessbach H, Niedrig M, von Brunn A, Wolf H.

Arch Virol. 1992;127(1-4):139-52.

PMID:
1456889
30.

Studies on processing, particle formation, and immunogenicity of the HIV-1 gag gene product: a possible component of a HIV vaccine.

Wagner R, Fliessbach H, Wanner G, Motz M, Niedrig M, Deby G, von Brunn A, Wolf H.

Arch Virol. 1992;127(1-4):117-37.

PMID:
1456888
32.

Productive infection of in vitro generated haemopoietic progenitor cells from normal human adult peripheral blood with parvovirus B19: studies by morphology, immunocytochemistry, flow-cytometry and DNA-hybridization.

Serke S, Schwarz TF, Baurmann H, Kirsch A, Hottenträger B, Von Brunn A, Roggendorf M, Huhn D, Deinhardt F.

Br J Haematol. 1991 Sep;79(1):6-13.

PMID:
1654995
33.
35.

Recombinant peripheral myelin protein P0 confers both adhesion and neurite outgrowth-promoting properties.

Schneider-Schaulies J, von Brunn A, Schachner M.

J Neurosci Res. 1990 Nov;27(3):286-97.

PMID:
1711125
36.

Development of the human immune response against the major surface protein (gp190) of Plasmodium falciparum.

Müller HM, Früh K, von Brunn A, Esposito F, Lombardi S, Crisanti A, Bujard H.

Infect Immun. 1989 Dec;57(12):3765-9.

37.

Transient synthesis of a specific set of proteins during the rapid cleavage phase of sea urchin development.

Grainger JL, von Brunn A, Winkler MM.

Dev Biol. 1986 Apr;114(2):403-15.

PMID:
3956873
38.

Supplemental Content

Loading ...
Support Center